Close Menu

At Science Progress, Britt Holbrook points out that the America COMPETES Reauthorization Act of 2010 is waiting to be voted on, and that while everyone seemed to be fixated on its $84 billion price tag, there is an overlooked aspect of the bill: its attempt to clarify the National Science Foundation's Broader Impacts Criterion policy. A subsection of this bill aims to explain what "broader impact" means by listing goals and policy recommendations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.